NEW YORK (Reuters Health) – By lowering heart rate, the selective sinoatrial current inhibitor ivabradine improves outcomes in patients with chronic heart failure and an elevated heart rate, according to findings reported August 29 at the European Society of Cardiology Annual Congress in Stockholm and...